Introduction
AstraZeneca, a leading biopharmaceutical company, partnered with Beamex to implement an integrated calibration solution across its Swedish operations. This initiative aimed to enhance efficiency and compliance with stringent industry regulations.

Background
AstraZeneca operates 30 manufacturing sites globally, with a significant presence in Södertälje, Sweden. The pharmaceutical industry is heavily regulated, necessitating precise calibration of equipment to ensure product quality and compliance with standards like the FDA's GMP requirements.

Implementation
In 2004, AstraZeneca Sweden Operations began integrating Beamex's CMX calibration management software. By 2005, the system was operational, transitioning from manual, paper-based processes to a fully digital system. This shift reduced the workforce required for calibrations from 50 to 15 employees, performing approximately 22,000 calibrations annually.

Challenges and Solutions
The transition involved unifying 12 databases and various workflows into a single, streamlined process. The Beamex CMX system, compliant with 21 CFR Part 11, facilitated this by providing a centralized database accessible across AstraZeneca's facilities. The use of PDAs for data entry and the server version of CMX enabled efficient data management and sharing.

Benefits
The new system reduced calibration intervals and labor intensity, improved process quality, and achieved a pay-off within one year. The number of databases was reduced from 12 to 1, and the process became less labor-intensive and more efficient.

Future Prospects
AstraZeneca plans to integrate the CMX193 system into its European SAP installation, potentially extending the benefits of this streamlined calibration process to other sites in the UK, Germany, and France.

Conclusion
The Beamex integrated calibration solution has significantly optimized AstraZeneca's operations, setting a benchmark for best practices in the pharmaceutical industry.